全文获取类型
收费全文 | 1497篇 |
免费 | 76篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 73篇 |
妇产科学 | 31篇 |
基础医学 | 216篇 |
口腔科学 | 15篇 |
临床医学 | 81篇 |
内科学 | 360篇 |
皮肤病学 | 25篇 |
神经病学 | 210篇 |
特种医学 | 33篇 |
外科学 | 231篇 |
综合类 | 13篇 |
预防医学 | 104篇 |
眼科学 | 19篇 |
药学 | 81篇 |
中国医学 | 10篇 |
肿瘤学 | 72篇 |
出版年
2023年 | 6篇 |
2022年 | 22篇 |
2021年 | 35篇 |
2020年 | 27篇 |
2019年 | 30篇 |
2018年 | 37篇 |
2017年 | 24篇 |
2016年 | 31篇 |
2015年 | 34篇 |
2014年 | 36篇 |
2013年 | 59篇 |
2012年 | 93篇 |
2011年 | 121篇 |
2010年 | 53篇 |
2009年 | 46篇 |
2008年 | 104篇 |
2007年 | 99篇 |
2006年 | 106篇 |
2005年 | 94篇 |
2004年 | 116篇 |
2003年 | 84篇 |
2002年 | 68篇 |
2001年 | 17篇 |
2000年 | 22篇 |
1999年 | 13篇 |
1998年 | 20篇 |
1997年 | 13篇 |
1996年 | 9篇 |
1995年 | 15篇 |
1994年 | 4篇 |
1993年 | 11篇 |
1992年 | 12篇 |
1991年 | 13篇 |
1990年 | 8篇 |
1989年 | 8篇 |
1988年 | 4篇 |
1987年 | 5篇 |
1986年 | 5篇 |
1985年 | 4篇 |
1984年 | 8篇 |
1983年 | 8篇 |
1982年 | 5篇 |
1981年 | 6篇 |
1980年 | 3篇 |
1979年 | 3篇 |
1978年 | 4篇 |
1977年 | 3篇 |
1976年 | 4篇 |
1972年 | 4篇 |
1928年 | 2篇 |
排序方式: 共有1579条查询结果,搜索用时 15 毫秒
21.
von Eckardstein S Noe G Brache V Nieschlag E Croxatto H Alvarez F Moo-Young A Sivin I Kumar N Small M Sundaram K;International Committee for Contraception Research The Population Council 《The Journal of clinical endocrinology and metabolism》2003,88(11):5232-5239
Several preparations of testosterone and its esters are being investigated alone or in combination with other gonadotropin-suppressing agents as possible antifertility agents for men. We studied the effectiveness of 7 alpha-methyl-19-nortestosterone (MENT) as an antispermatogenic agent in men. MENT has been shown to be more potent than testosterone and to be resistant to 5 alpha-reduction. For sustained delivery of MENT, we used a system consisting of ethylene vinyl acetate implants containing MENT acetate (Ac), administered subdermally. Thirty-five normal volunteers were recruited in 3 clinics and were randomly assigned to 1 of 3 doses: 1 (12 men), 2 (11 men), or 4 (12 men) MENT Ac implants. The initial average in vitro release rate of MENT Ac from each implant was approximately 400 micro g/day. Implants were inserted subdermally in the medial aspect of the upper arm under local anesthesia. The duration of treatment was initially designed to be 6 months. However, in 2 clinics the duration of treatment was extended to 9 months for the 2-implant group and to 12 months for the 4-implant group. Dose-related increases in serum MENT levels and decreases in testosterone, LH, and FSH levels were observed. Effects on sperm counts were also dose related. None of the subjects in the 1-implant group exhibited oligozoospermia (sperm count, <3 million/ml). Four subjects in the 2-implant group became oligozoospermic, 2 of whom reached azoospermia. Eight subjects in the 4-implant group reached azoospermia, with 1 exhibiting oligozoospermia, whereas 2 were nonresponders. Side effects generally seen with androgen administration, such as increases in erythrocyte count, hematocrit, and hemoglobin and a decrease in SHBG, were also seen in this study and were reversible. Changes in lipid parameters were moderate and transient. Liver enzymes showed small changes. This study demonstrates that MENT Ac, when administered in a sustained release fashion via subdermal implants, can inhibit spermatogenesis over a prolonged period after a single administration and has the potential to be used as a male contraceptive. 相似文献
22.
23.
24.
STUDY OBJECTIVE: To test the hypothesis that haplotypes of the interleukin (IL)-10 gene are associated with clinical outcomes, comparing critically ill patients with sepsis from pneumonia vs those with extrapulmonary sepsis. DESIGN: Genetic association study. SETTING: Medical/surgical ICUs in a tertiary-care, university-affiliated teaching hospital. PATIENTS: Of 550 white patients with sepsis, 158 had pneumonia as the principle cause of their sepsis and 392 had an extrapulmonary source of sepsis. MEASUREMENTS: Haplotypes of the IL-10 gene were defined by measurement of haplotype tag single-nucleotide polymorphisms (SNPs). Primary outcome was 28-day survival. Secondary outcomes were days alive and free of organ dysfunction. RESULTS: Three SNPs in the IL-10 gene (-592 C/A, +734 G/T, and +3367 G/A) identified four major haplotypes: CGG, AGG, CTA, and CTG. Patients with pneumonia who carried one or two copies of the CGG haplotype had greater 28-day mortality (51.4%) than patients who did not carry this haplotype (29.1%, p = 0.007). Carriers of CGG had significantly more cardiovascular dysfunction (and use of vasopressors), renal dysfunction (and requirement of dialysis), hepatic dysfunction, and hematologic dysfunction (p < 0.05 in each case). In contrast, in patients with an extrapulmonary source of infection there was no significant association of the CGG haplotype (or any measured IL-10 genotype) with 28-day mortality or organ dysfunction. CONCLUSIONS: The IL-10 haplotype - 592C/734G/3367G is associated with increased mortality and organ dysfunction in critically ill patients with pulmonary sepsis but not in similarly ill patients with extrapulmonary sepsis. Therefore, polymorphisms within the IL-10 gene may be predictors of outcome in patients with sepsis from pneumonia. 相似文献
25.
26.
Kaufmann Horacio Vickery Ross Wang Whedy Kanodia Jitendra Shibao Cyndya A. Norcliffe-Kaufmann Lucy Haumann Brett Biaggioni Italo 《Clinical autonomic research》2021,31(6):699-711
Clinical Autonomic Research - In neurogenic orthostatic hypotension, blood pressure falls when upright owing to impaired release of norepinephrine, leading to dizziness. Ampreloxetine, a selective... 相似文献
27.
28.
de los Angeles Pando M Biglione MM Toscano MF Rey JA Russell KL Negrete M Gianni S Martinez-Peralta L Salomon H Sosa-Estani S Montano SM Olson JG Sanchez JL Carr JK Avila MM 《The American journal of tropical medicine and hygiene》2004,71(2):153-159
Infections with hepatitis C virus, (HCV), hepatitis B virus (HBV), and human T lymphotropic type I/II (HTLV-I/II) virus are commonly found in patients infected with human immunodeficiency virus type 1 (HIV-1). We conducted a seroepidemiologic study among 174 HIV-positive heterosexuals in Buenos Aires, Argentina in 1999. Evidence of exposure to HCV, HBV, and HTLV-I/II was found in 32%, 17%, and 5%, respectively. A higher prevalence of HBV infection was observed among males (33%) compared with females (12%; P < 0.05). Among women, a prior history of a sexually transmitted infection, injecting drug use (IDU), having had more than five lifetime sex partners, and having exchanged sex-for-goods were significantly associated with HCV infection, whereas an IDU history, syringe sharing, and having exchanged sex-for-goods were found to be associated with HBV infection. Among men, an IDU history and syringe/needle sharing were significantly associated with HCV infection. The IDU-related and sexual transmission of hepatitis viruses constitute a significant problem among young, HIV-infected, heterosexuals in Argentina. 相似文献
29.
Diego Fernández-Rodríguez José J. Grillo-Pérez Horacio Pérez-Hernández Marcos Rodríguez-Esteban Raquel Pimienta Carlos Acosta-Materán Sara Rodríguez Geoffrey Yanes-Bowden Manuel J. Vargas-Torres Alejandro Sánchez-Grande Flecha Julio Hernández-Afonso Francisco Bosa-Ojeda 《Nefrología : publicación oficial de la Sociedad Espa?ola Nefrologia》2018,38(2):169-178
Introduction and objectives
Rotational coronary angiography (RCA) requires less contrast to be administered and can prevent the onset of contrast-induced nephropathy (CIN) during invasive coronary procedures. The aim of the study is to evaluate the impact of RCA on CIN (increase in serum creatinine ≥0.5 mg/dl or ≥25%) after an acute coronary syndrome.Methods
From April to September 2016, patients suffering acute coronary syndromes who underwent diagnostic coronary angiography, with the possibility of ad hoc coronary angioplasty, were prospectively enrolled. At the operator's discretion, patients underwent RCA or conventional coronary angiography (CCA). CIN (primary endpoint), as well as analytical, angiographic and clinical endpoints, were compared between groups.Results
Of the 235 patients enrolled, 116 patients received RCA and 119 patients received CCA. The RCA group was composed of older patients (64.0 ± 11.8 years vs. 59.7 ± 12.1 years; p = 0.006), a higher proportion of women (44.8 vs. 17.6%; p < 0.001), patients with a lower estimated glomerular filtration rate (76 ± 25 vs. 86 ± 27 ml/min/1.73 m2; p = 0.001), and patients who underwent fewer coronary angioplasties (p < 0.001) compared with the CCA group. Furthermore, the RCA group, received less contrast (113 ± 92 vs. 169 ± 103 ml; p < 0.001), including in diagnostic procedures (54 ± 24 vs. 85 ± 56 ml; p < 0.001) and diagnostic-therapeutic procedures (174 ± 64 vs. 205 ± 98 ml; p = 0.049) compared with the CCA group. The RCA group presented less CIN (4.3 vs. 22.7%; p < 0.001) compared to the CCA group, and this finding was maintained in the regression analysis (Adjusted relative risk: 0.868; 95% CI: 0.794-0.949; p = 0.002). There were no differences in clinical endpoints between the groups.Conclusions
RCA was associated with lower administration of contrast during invasive coronary procedures in acute coronary syndrome patients, resulting in lower incidence of CIN, in comparison with CCA. 相似文献30.
Tacrolimus (FK 506), a Treatment for Primary Sclerosing Cholangitis: Results of an Open-Label Preliminary Trial 总被引:5,自引:0,他引:5
David H. Van Thiel M.D. Patricia Carroll M.D. Kareem Abu-Elmagd M.D. Horacio Rodriguez-Rilo M.D. William Irish M.Sc. John McMichael B.Sc. Thomas E. Starzl M.D. Ph.D. 《The American journal of gastroenterology》1995,90(3):455-459
Primary sclerosing cholangitis (PSC) is a chronic inflammatory disease of the liver that is characterized by progressive cholestasis and the development of secondary biliary cirrhosis. There is no widely recognized therapy for this disease, although anti-inflammatory agents (steroids), immunosuppressive agents (methotrexate), anti-fihrotics (colchicine), and choleretic agents (ursodeoxycholic acid) have been used in various small series. In the present study, Tacrolimus (FK 506), a new and powerful immunosuppressive macrolide antibiotic, has been used to treat 10 patients with PSC. Each subject had a liver biopsy, ERCP with visualization of the intra-and extrahepatic biliary tree, and a panel of hcmatological, serological, and biochemical laboratory tests before the initiation of the FK 506 therapy. The FK 506 was administered orally at 12-h intervals and was monitored by serial plasma FK 506 trough levels. After 360 days of treatment, the median serum bilirubin level was reduced by 75%, and the serum alkaline phosphatase was reduced by 70%. Moreover, the serum ALT and AST levels were reduced by 80 and 86%, respectively. No change in the serum level of BUN and creatinine levels occurred as a consequence of the FK 506 treatment. These data demonstrate that: 1) FK 506 can be used to treat PSC; 2) the response to FK 506 by patients with PSC is rapid; and, 3) no adverse effect on the serum BUN and creatinine levels was observed. It is anticipated that FK 506 will become an important agent for the treatment of patients with PSC because of its powerful immunosuppressive activity. 相似文献